The effect of food on ciramadol bioavailability in normal subjects. 1987

P R Audet, and S Chiang, and A Maroli, and A Locniskar, and G Morrison

Eleven healthy volunteers completed a study to compare the relative bioavailability to orally administered ciramadol in a fasting versus postprandial state. A single oral dose of 30 mg of ciramadol was administered on two separate occasions, 2 weeks apart, in a randomized crossover study. A mono- or biexponential pharmacokinetic equation with first-order absorption was applied to analyse the serum data for each subject. Significant differences were found in peak time (tmax) and absorption time (tabs) whereas the mean AUCs for the two modes of administration were not significantly different. The relative bioavailability (F) of the drug when administered in the postprandial state with respect to the fasting state was 96 per cent. It is thus concluded that ingestion of food has no effect on the extent of absorption of ciramadol; however, food may alter its rate of absorption.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D005260 Female Females
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D001596 Benzylamines Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group. Phenylmethylamine,alpha-Aminotoluene,alpha Aminotoluene
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

P R Audet, and S Chiang, and A Maroli, and A Locniskar, and G Morrison
January 1982, Journal of clinical pharmacology,
P R Audet, and S Chiang, and A Maroli, and A Locniskar, and G Morrison
January 1974, Journal of clinical pharmacology,
P R Audet, and S Chiang, and A Maroli, and A Locniskar, and G Morrison
March 1988, International journal of clinical pharmacology, therapy, and toxicology,
P R Audet, and S Chiang, and A Maroli, and A Locniskar, and G Morrison
September 1994, Die Pharmazie,
P R Audet, and S Chiang, and A Maroli, and A Locniskar, and G Morrison
September 1998, Antimicrobial agents and chemotherapy,
P R Audet, and S Chiang, and A Maroli, and A Locniskar, and G Morrison
June 2017, Clinical drug investigation,
P R Audet, and S Chiang, and A Maroli, and A Locniskar, and G Morrison
January 1980, Annual review of pharmacology and toxicology,
P R Audet, and S Chiang, and A Maroli, and A Locniskar, and G Morrison
February 1994, Journal of pharmaceutical sciences,
P R Audet, and S Chiang, and A Maroli, and A Locniskar, and G Morrison
September 1985, Journal of clinical pharmacology,
P R Audet, and S Chiang, and A Maroli, and A Locniskar, and G Morrison
January 1986, European journal of clinical pharmacology,
Copied contents to your clipboard!